secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2026-07-30T16:02:58+00:00
Accession:  0001640334-26-001258
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience announces 1-for-15 reverse stock split effective Aug 3, 2026 to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split ratio 1-for-15; effective 12:01 a.m. ET on August 3, 2026.
- Outstanding shares reduced from ~24.8M to ~1.65M; authorized shares cut from 220M to 14.7M.
- Primary goal: regain Nasdaq minimum $1.00 bid price compliance under Listing Rule 5550(a)(2).
- No fractional shares issued; fractional shares rounded up to whole shares.
- Stock symbol LEXX unchanged; new CUSIP 52886N604.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426001258/0001640334-26-001258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033426001258/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer